Ramachandra Sumant 4
4 · Lyell Immunopharma, Inc. · Filed Nov 1, 2024
Insider Transaction Report
Form 4
Ramachandra Sumant
Director
Transactions
- Award
Option (right to buy)
2024-10-31+260,000→ 260,000 totalExercise: $0.96Exp: 2034-10-30→ Common Stock (260,000 underlying)
Footnotes (1)
- [F1]One thirty-sixth (1/36th) of the shares of common stock subject to the option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month), subject to the reporting person providing service through the applicable vesting date.